{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T09:16:30Z","timestamp":1649063790760},"reference-count":27,"publisher":"Institute of Biochemistry","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BIOMED KHIM"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Schizophrenia is one of the most serious and common mental disorders, which is characterized by high levels  of pathogenic heterogeneity as well as neuroimmune abnormalities, which require treatment with antipsychotic drugs.  Monoamines are one of the key neurotransmitters which play an important role in neuroimmune interactions of the human  organism. We suggest that the quantity of the monoamine receptors on mononuclear cells of the peripheral  blood (PBMCs) can be associated with the cytokine profile of patients. With this quantity being a key component  of the mental status correction mechanism in antipsychotic therapy. In this study we measured cytokine levels  (IL-6, IL-1b and TGF-b) in blood serum, the protein expression status of the serotonin receptor 5HTR2A  and the dopamine receptors D1 (DRD1), DRD2, DRD3 in PBMCs of drug-naive, first episode schizophrenia  patients before and after the treatment with olanzapine and haloperidol. This study has shown for the first time that  the antipsychotic therapy leads to a decrease in protein levels of monoamine receptors in PBMCs associated  with the affinity of the drug used. Blood cytokine levels were significantly higher in serum from studied  patients as compared with the reference values. The antipsychotic-linked change of the TGF-b production caused by  the therapy is probably associated with the reduction of various monoamine receptors. The relationship between  the psychopathological status and the protein level of 5THR2A suggests that the amount of 5HTR2A may serve  as a potential biomarker for the personalized appointment of the antipsychotic therapy.<\/jats:p>","DOI":"10.18097\/pbmc20186402201","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T06:55:49Z","timestamp":1524812149000},"page":"201-207","source":"Crossref","is-referenced-by-count":1,"title":["The effect of antipsychotic drug on monoamine receptors in peripheral blood mononuclear cells: affinity linked mechanism"],"prefix":"10.18097","volume":"64","author":[{"given":"A.E.","family":"Taraskina","sequence":"first","affiliation":[{"name":"Konstantinov Petersburg Nuclear Physics Institute of National Research Centre \u201cKurchatov Institute\u201d, Leningrad district, Gatchina, Russia; Pavlov First Saint Petersburg State Medical University, Saint-Peterburg, Russia; Bekhterev National Medical Research Center Psychiatry and Neurology, Saint-Peterburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Zabotina","sequence":"additional","affiliation":[{"name":"Konstantinov Petersburg Nuclear Physics Institute of National Research Centre \u201cKurchatov Institute\u201d, Leningrad district, Gatchina, Russia; Pavlov First Saint Petersburg State Medical University, Saint-Peterburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.F.","family":"Nasyrova","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center Psychiatry and Neurology, Saint-Peterburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.N.","family":"Sosin","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center Psychiatry and Neurology, Saint-Peterburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.A.","family":"Sosina","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center Psychiatry and Neurology, Saint-Peterburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.E.","family":"Ershov","sequence":"additional","affiliation":[{"name":"Kashchenko Saint Petersburg Psychiatric Hospital no.1, Saint-Peterburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.N.","family":"Grunina","sequence":"additional","affiliation":[{"name":"Konstantinov Petersburg Nuclear Physics Institute of National Research Centre \u201cKurchatov Institute\u201d, Leningrad district, Gatchina, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.","family":"Krupitsky","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center Psychiatry and Neurology, Saint-Peterburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7443","published-online":{"date-parts":[[2018]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Consentino M., Fietta A.M., Ferrari M., Rasini E., Bombelli R., Carcano E., Saporiti F., Meloni F., Marino F., Lecchini S. (2007) Blood, 109(2), 632-642.","DOI":"10.1182\/blood-2006-01-028423"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Ferreira T.B., Kasahara T.M., Barros P.O., Vieira M.M.M., Bittencourt V.C.B., Hygino J., Andrade R.M., Linhares U.C., Andrade A.F., Bento C.A. (2011) J. Neuroimmunol., 238, 58-66.","DOI":"10.1016\/j.jneuroim.2011.06.009"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Lychkova A.E., Puzikov A.M. (2014) Uspekhi fiziologicheskikh nauk, 45(4), 69-88.","DOI":"10.4213\/rm9635"},{"key":"ref4","unstructured":"Pacheco R., Contreras F., Zouali M. (2014) Front. Immunol., 5(117), 1-17."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Levite M. (2016) Acta Physiol., 216, 42-89.","DOI":"10.1111\/apha.12476"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Fernandez-Eqea E., Vertes P.E., Flint S.M., Turner L., Mustafa S., Hatton A., Smith K.G.C., Lyons P.A., Bullmore E.T. (2016) Plos ONE, 11(5), e0155631.","DOI":"10.1371\/journal.pone.0155631"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Mikulak J., Bozzo L., Roberto A., Pontarini E., Tentorio P., Hudspeth K., Lungli E., Mavilio D. (2014) J. Immunol., 193, 2792-2800.","DOI":"10.4049\/jimmunol.1401114"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Kubesova A., Tejkalova H., Syslova K., Kacer P., Vondrousova J., Tyls F., Fujakova M., Palenicek T., Horacek J. (2015) Plos ONE, 10(1), e0115439.","DOI":"10.1371\/journal.pone.0115439"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Chiappelli J., Postolache T.T., Kochunov P., Rowland L.M., Wijtenburg S.A., Shukla D.K., Tagamets M., Du X., Savransky A., Lowry C.A., Can A., Fuchs D., Hong L.E. (2016) Neuropsychopharmacology, 41, 2587-2595.","DOI":"10.1038\/npp.2016.66"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Reus G.Z., Fries G.R., Stertz L., Badawy M., Passos I.C., Barichello T., Kapczinski F., Quevedo J. (2015) Neuroscience, 300, 141-154.","DOI":"10.1016\/j.neuroscience.2015.05.018"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Khandaker G.M., Cousins L., Deakin J., Lennox B.R., Yolken R., Jones P.B. (2015) Lancet Psychiatry, 2(3), 258-270.","DOI":"10.1016\/S2215-0366(14)00122-9"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Najjar S., Pearlman D.M. (2015) Schizophrenia Res., 161, 102-112.","DOI":"10.1016\/j.schres.2014.04.041"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Lopez A.D., Murray C.C. (1998) Nat. Med., 4, 1241-1243.","DOI":"10.1038\/3218"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Moore T.R., Hill A.M., Panguluri S.K. (2014) Recent Patents on Biotechnology, 8, 152-159.","DOI":"10.2174\/1872208309666140904113615"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Schmitt A., Bertsch T., Tost H., Bergmann A., Henning U., Klimke A., Falkai P. (2005) Neuropsychiatric Disease and Treatment, 1(2), 171-177.","DOI":"10.2147\/nedt.1.2.171.61048"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Dennison U., McKernan D., Cryan J., Dinan T. (2012) Psychological Medicine, 42, 1865-1871.","DOI":"10.1017\/S0033291712000074"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Song X., Fan X., Song X., Zhang J., Zhang W., Li X., Gao J., Harrington A., Ziedonis D., Lv L. (2013) Schizophrenia Res., 150, 269-273.","DOI":"10.1016\/j.schres.2013.07.044"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Cai H.L., Fang P.F., Li H.D., Zhang X.H., Hu L., Yang W., Ye H.S. (2011) Psychiatry Res., 188(2), 197-202.","DOI":"10.1016\/j.psychres.2010.11.003"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. (2011) Biol. Psychiatry, 70, 663-671.","DOI":"10.1016\/j.biopsych.2011.04.013"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Tourjman V., Kouassi E., Koue M.-E., Rocchetti M., Fortin-Fournier S., Fusar-Poli P., Potvin S. (2013) Schizophrenia Res., 151, 43-47.","DOI":"10.1016\/j.schres.2013.10.011"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Buttarelli F.R., Fanciulli A., Pellicano C., Pontieri F.E. (2011) Current Neuropharmacology, 9, 278-288.","DOI":"10.2174\/157015911795596612"},{"key":"ref22","unstructured":"Kay S.R., Fiszbein A., Opler L.A. (1987) Schizophr. Bull., 13(2), 261-76."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Kubera M., Maes M., Kenis G., Kim Y.-K., Lason W. (2005) Psychiatry Res., 134, 251-258.","DOI":"10.1016\/j.psychres.2004.01.014"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Inoue M., Okazaki T., Kitazono T., Mizushima M., Omata M., Ozaki S. (2011) International Immunopharmacol., 11, 67-73.","DOI":"10.1016\/j.intimp.2010.10.007"},{"key":"ref25","unstructured":"Taraskina A.E., Morozova M.N., Bychkova N.V., Davydova N.I., Shvartsman A.L. (2012) Rossijskij immunologicheskij zhurnal, 6(15), \u2116 3, 273-280."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"McKenna F., McLaughlin P.J., Lewis B.J., Sibbring G.C., Cummerson J.A., Bowen-Jones D., Moots R.J. (2002) J. Neuroimmunol., 132(1-2), 34-40.","DOI":"10.1016\/S0165-5728(02)00280-1"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Kustrimovic N., Rasini E., Legnaro M., Marino F., Cosentino M. (2014) J.Neuroimmune Pharmacol., 9, 302-312.","DOI":"10.1007\/s11481-014-9541-5"}],"container-title":["Biomeditsinskaya Khimiya"],"original-title":[],"language":"ru","deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T11:54:16Z","timestamp":1568634856000},"score":1,"resource":{"primary":{"URL":"http:\/\/pbmc.ibmc.msk.ru\/en\/article-en\/PBMC-2018-64-2-201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018]]},"published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.18097\/pbmc20186402201","relation":{},"ISSN":["2310-6905","2310-6972"],"issn-type":[{"value":"2310-6905","type":"electronic"},{"value":"2310-6972","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}